PL2863950T3 - Aminotriazolopirydyna do zastosowania w leczeniu zapalenia i jej kompozycje farmaceutyczne - Google Patents

Aminotriazolopirydyna do zastosowania w leczeniu zapalenia i jej kompozycje farmaceutyczne

Info

Publication number: PL2863950T3
Authority: PL; Poland
Prior art keywords: aminotriazolopyridine; inflammation; treatment; pharmaceutical compositions; pharmaceutical
Prior art date: 2012-06-22

Application number

PL13727625T

Other languages

English (en)

Inventor

Gerben Albert Eleutherius Van 't Klooster

Reginald Christophe Xavier Brys

Luc Juliaan Corina Van Rompaey

Florence Sylvie Namour

Original Assignee

Galapagos Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-22

Filing date

2013-06-10

Publication date

2019-02-28

2013-06-10 Application filed by Galapagos Nv filed Critical Galapagos Nv

2019-02-28 Publication of PL2863950T3 publication Critical patent/PL2863950T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Oncology (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)

PL13727625T 2012-06-22 2013-06-10 Aminotriazolopirydyna do zastosowania w leczeniu zapalenia i jej kompozycje farmaceutyczne PL2863950T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261663520P	2012-06-22	2012-06-22
EP13727625.9A EP2863950B1 (en)	2012-06-22	2013-06-10	Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
PCT/EP2013/061914 WO2013189771A1 (en)	2012-06-22	2013-06-10	Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof

Publications (1)

Publication Number	Publication Date
PL2863950T3 true PL2863950T3 (pl)	2019-02-28

Family

ID=48577773

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13727625T PL2863950T3 (pl)	2012-06-22	2013-06-10	Aminotriazolopirydyna do zastosowania w leczeniu zapalenia i jej kompozycje farmaceutyczne

Country Status (34)

Country	Link
US (2)	US9284311B2 (pl)
EP (1)	EP2863950B1 (pl)
JP (2)	JP6238975B2 (pl)
KR (1)	KR102078069B1 (pl)
CN (2)	CN107998136A (pl)
AR (1)	AR091395A1 (pl)
AU (1)	AU2013279597B2 (pl)
BR (1)	BR112014031626A8 (pl)
CA (1)	CA2875619C (pl)
CL (1)	CL2014003462A1 (pl)
CO (1)	CO7160085A2 (pl)
CR (1)	CR20140583A (pl)
CY (1)	CY1120643T1 (pl)
DK (1)	DK2863950T3 (pl)
EA (1)	EA029084B1 (pl)
ES (1)	ES2685985T3 (pl)
HR (1)	HRP20181364T8 (pl)
HU (1)	HUE038878T2 (pl)
IL (1)	IL235923B (pl)
LT (1)	LT2863950T (pl)
MA (1)	MA37775A1 (pl)
MX (1)	MX368511B (pl)
MY (1)	MY177334A (pl)
NZ (1)	NZ702480A (pl)
PE (1)	PE20150187A1 (pl)
PH (1)	PH12014502615A1 (pl)
PL (1)	PL2863950T3 (pl)
PT (1)	PT2863950T (pl)
SG (2)	SG11201408123SA (pl)
SI (1)	SI2863950T1 (pl)
TW (1)	TWI586352B (pl)
UA (1)	UA112804C2 (pl)
UY (1)	UY34855A (pl)
WO (1)	WO2013189771A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO3041B1 (ar)	2008-07-25	2016-09-05	Galapagos Nv	مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
TWI462920B (zh)	2009-06-26	2014-12-01	葛萊伯格有限公司	用於治療退化性及發炎疾病之新穎化合物
GB201402070D0 (en)	2014-02-07	2014-03-26	Galapagos Nv	Pharmaceutical compositions for the treatment of inflammatory disorders
GB201402071D0 (en) *	2014-02-07	2014-03-26	Galapagos Nv	Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
JP2018511620A (ja)	2015-04-13	2018-04-26	ガラパゴス・ナムローゼ・フェンノートシャップＧａｌａｐａｇｏｓＮ．Ｖ．	炎症性障害の治療のための方法
AU2016248727B2 (en) *	2015-04-13	2021-04-01	Alfasigma S.P.A.	Methods for the treatment of cardiovascular disorders
AU2016257892A1 (en) *	2015-05-05	2017-11-09	Concert Pharmaceuticals, Inc.	Deuterated filgotinib
CN105061420B (zh) *	2015-06-04	2017-09-05	南京旗昌医药科技有限公司	一种jak抑制剂的晶型及其制备方法和应用
WO2017106566A1 (en)	2015-12-17	2017-06-22	Gilead Sciences, Inc.	Combination of a jak inhibitor and an mmp9 binding protein for treating inflammatory disorders
US20170173034A1 (en)	2015-12-17	2017-06-22	Gilead Sciences, Inc.	Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders
WO2017106568A1 (en)	2015-12-17	2017-06-22	Gilead Sciences, Inc.	Combination of a jak inhibitor and a bromodomain inhibitor for treating cancer
CN112851682B (zh) *	2016-02-02	2022-10-25	深圳市塔吉瑞生物医药有限公司	一种取代的吡啶酰胺类化合物及其应用
CA3043396A1 (en)	2016-11-10	2018-05-17	Galapagos Nv	Compounds and pharmaceutical compositions thereof for the treatment of inflammatory diseases
GB201702603D0 (en)	2017-02-17	2017-04-05	Galápagos Nv	Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201808575D0 (en) *	2018-05-24	2018-07-11	Galapagos Nv	Methods for the treatment of psoriatic arthrits
US12171764B2 (en)	2018-06-20	2024-12-24	Biora Therapeutics, Inc.	Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
JP2022527512A (ja) *	2019-03-30	2022-06-02	ユニケムラボラトリーズリミテッド	フィルゴチニブおよびその中間体の調製のための新規プロセス
JP7315166B2 (ja) *	2019-06-10	2023-07-26	富士通株式会社	グラフェンナノリボンネットワーク膜の製造方法及び電子装置の製造方法
CN111686106B (zh) *	2020-04-05	2022-07-15	温州医科大学附属第一医院	提高Dicer表达的化合物在制备药物中的应用
CN114409675B (zh) *	2022-01-07	2023-08-04	重庆医科大学	螺环异恶唑酮色满衍生物在制备用于治疗jak1介导的疾病药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2662074A1 (en) *	2006-08-30	2008-03-06	Cellzome Limited	Triazole derivatives as kinase inhibitors
TWI453207B (zh) *	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
CA2763900A1 (en) *	2009-06-05	2010-12-09	Cephalon, Inc.	Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
TWI462920B (zh) *	2009-06-26	2014-12-01	葛萊伯格有限公司	用於治療退化性及發炎疾病之新穎化合物
JO3030B1 (ar) *	2009-06-26	2016-09-05	Galapagos Nv	مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات

2013
- 2013-06-10 EP EP13727625.9A patent/EP2863950B1/en active Active
- 2013-06-10 JP JP2015517666A patent/JP6238975B2/ja active Active
- 2013-06-10 US US13/913,597 patent/US9284311B2/en active Active
- 2013-06-10 AU AU2013279597A patent/AU2013279597B2/en active Active
- 2013-06-10 CA CA2875619A patent/CA2875619C/en active Active
- 2013-06-10 BR BR112014031626A patent/BR112014031626A8/pt not_active Application Discontinuation
- 2013-06-10 CN CN201810014031.0A patent/CN107998136A/zh active Pending
- 2013-06-10 PL PL13727625T patent/PL2863950T3/pl unknown
- 2013-06-10 ES ES13727625.9T patent/ES2685985T3/es active Active
- 2013-06-10 MA MA37775A patent/MA37775A1/fr unknown
- 2013-06-10 UY UY0001034855A patent/UY34855A/es unknown
- 2013-06-10 HU HUE13727625A patent/HUE038878T2/hu unknown
- 2013-06-10 WO PCT/EP2013/061914 patent/WO2013189771A1/en not_active Ceased
- 2013-06-10 LT LTEP13727625.9T patent/LT2863950T/lt unknown
- 2013-06-10 CN CN201380032159.5A patent/CN104379173A/zh active Pending
- 2013-06-10 AR ARP130102033 patent/AR091395A1/es unknown
- 2013-06-10 SG SG11201408123SA patent/SG11201408123SA/en unknown
- 2013-06-10 NZ NZ702480A patent/NZ702480A/en unknown
- 2013-06-10 HR HRP20181364TT patent/HRP20181364T8/hr unknown
- 2013-06-10 PT PT13727625T patent/PT2863950T/pt unknown
- 2013-06-10 PE PE2014002472A patent/PE20150187A1/es not_active Application Discontinuation
- 2013-06-10 EA EA201590071A patent/EA029084B1/ru unknown
- 2013-06-10 KR KR1020157001521A patent/KR102078069B1/ko active Active
- 2013-06-10 SG SG10201700125VA patent/SG10201700125VA/en unknown
- 2013-06-10 MX MX2014014800A patent/MX368511B/es active IP Right Grant
- 2013-06-10 MY MYPI2014703876A patent/MY177334A/en unknown
- 2013-06-10 DK DK13727625.9T patent/DK2863950T3/en active
- 2013-06-10 SI SI201331137T patent/SI2863950T1/sl unknown
- 2013-06-11 TW TW102120793A patent/TWI586352B/zh active
- 2013-10-06 UA UAA201500458A patent/UA112804C2/uk unknown
2014
- 2014-11-24 PH PH12014502615A patent/PH12014502615A1/en unknown
- 2014-11-26 IL IL235923A patent/IL235923B/en active IP Right Grant
- 2014-12-16 CR CR20140583A patent/CR20140583A/es unknown
- 2014-12-19 CL CL2014003462A patent/CL2014003462A1/es unknown
- 2014-12-19 CO CO14279834A patent/CO7160085A2/es unknown
2016
- 2016-03-14 US US15/069,130 patent/US20160296529A1/en not_active Abandoned
2017
- 2017-10-31 JP JP2017210372A patent/JP2018048185A/ja active Pending
2018
- 2018-08-29 CY CY181100902T patent/CY1120643T1/el unknown

Also Published As

Publication number	Publication date
HRP20181364T8 (hr)	2018-12-28
PH12014502615B1 (en)	2015-01-21
MX2014014800A (es)	2015-02-12
TWI586352B (zh)	2017-06-11
UA112804C2 (uk)	2016-10-25
BR112014031626A2 (pt)	2017-06-27
MY177334A (en)	2020-09-12
JP2018048185A (ja)	2018-03-29
HUE038878T2 (hu)	2018-12-28
EA201590071A1 (ru)	2015-04-30
US9284311B2 (en)	2016-03-15
BR112014031626A8 (pt)	2021-10-19
KR102078069B1 (ko)	2020-02-17
AU2013279597B2 (en)	2017-04-20
WO2013189771A1 (en)	2013-12-27
IL235923B (en)	2018-11-29
IL235923A0 (en)	2015-01-29
EP2863950B1 (en)	2018-07-18
EP2863950A1 (en)	2015-04-29
PH12014502615A1 (en)	2015-01-21
CN107998136A (zh)	2018-05-08
UY34855A (es)	2014-01-31
LT2863950T (lt)	2018-09-25
CA2875619A1 (en)	2013-12-27
MA37775A1 (fr)	2017-04-28
CL2014003462A1 (es)	2015-02-27
AU2013279597A1 (en)	2015-01-15
HK1208368A1 (en)	2016-03-04
TW201400114A (zh)	2014-01-01
US20130345209A1 (en)	2013-12-26
KR20150023048A (ko)	2015-03-04
JP2015520198A (ja)	2015-07-16
MX368511B (es)	2019-10-07
JP6238975B2 (ja)	2017-11-29
PE20150187A1 (es)	2015-02-27
SI2863950T1 (sl)	2018-10-30
CO7160085A2 (es)	2015-01-15
CY1120643T1 (el)	2019-12-11
AR091395A1 (es)	2015-02-04
HRP20181364T1 (hr)	2018-10-19
SG11201408123SA (en)	2015-01-29
PT2863950T (pt)	2018-10-10
CA2875619C (en)	2020-11-24
NZ702480A (en)	2016-11-25
CR20140583A (es)	2015-02-10
SG10201700125VA (en)	2017-02-27
US20160296529A1 (en)	2016-10-13
ES2685985T3 (es)	2018-10-15
DK2863950T3 (en)	2018-09-03
EA029084B1 (ru)	2018-02-28
CN104379173A (zh)	2015-02-25

Publication	Publication Date	Title
IL235923B (en)	2018-11-29	Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
IL231536A (en)	2016-09-29	Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
ZA201406233B (en)	2015-11-25	Pharmaceutical composition and administration thereof
IL236221A (en)	2017-12-31	History of theophyridone and pharmacological preparations containing them for the treatment of diseases
IL234628A0 (en)	2014-11-30	Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
IL252566B (en)	2020-07-30	Pharmacy preparations and methods
IL234884A0 (en)	2014-12-31	Inhibitors of kynurenine-3-monooxygenase pharmaceutical compositions, and methods of their use
GB2501611B (en)	2015-03-04	Alpha-2-macroglobulin compositions and therapeutic uses
IL237125A0 (en)	2015-03-31	Use of preparations containing niclosamide and/or its derivatives for the treatment of solid tumors
ZA201408055B (en)	2016-03-30	Compositions and methods for the treatment of local pain
GB201222455D0 (en)	2013-01-30	Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
IL244901A0 (en)	2016-05-31	Derivatives of aminotetralin and aminoindan, pharmaceutical compositions containing them and their use in therapy
IL233825A (en)	2017-03-30	H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
EP2685993A4 (en)	2014-11-19	PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF
IL235830A0 (en)	2015-01-29	New dosage and formulation
SI2874600T1 (sl)	2016-10-28	Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu
GB2504390B (en)	2015-06-03	Nutraceutical and pharmaceutical composition
PL2854748T3 (pl)	2018-01-31	Kompozycja farmaceutyczna do leczenia zapalenia skóry i powiązanych syndromów
GB201208315D0 (en)	2012-06-27	Pharmaceutical methods and compositions
SG11201500838UA (en)	2015-03-30	Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
ZA201503799B (en)	2016-02-24	Fixed dose pharmaceutical composition comprising mometasone and azelastine
GB201207064D0 (en)	2012-06-06	Pharmaceutical compositions comprising 15-hetre and methods of using the same
HK1228390A1 (en)	2017-11-03	Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
ZA201404052B (en)	2016-05-25	18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in treatment of endometriosis
ZA201303790B (en)	2014-04-30	Formulation useful for treating pain and/or inflammation